Retatrutide is a single-molecule triple agonist: It activates GIP, GLP-1, and glucagon receptors in one peptide
Research shows that a low-protein diet helps slow the progression of chronic kidney disease
ATGL, HSL, MGL, lipid-droplet proteins, coactivators, inhibitory proteins, intracellular localization, and substrate accessibility all influence the measured rate of lipid mobilization
While topical products may be adequate for mild surface-level concerns, addressing established skin laxity with significant collagen and elastin loss typically requires the higher tissue concentrations achievable through injection
Use only as directed on unbroken skin
Discover the full range of TB500 peptide products and their benefits here